News - Page 4 of 7 - Applied BioCode

2023 News & Press Releases

Applied BioCode Announces Distribution Agreement with Medline Industries

05/08/2023

Applied BioCode today announced an agreement with Medline Industries, a leading manufacturer and distributor of healthcare products, to distribute the …

2023 News & Press Releases

How to Improve Accessibility to Testing for GI Infections

03/22/2023

Infectious diarrhea also known as gastroenteritis, is a leading cause of death worldwide and a serious health risk to the …

2023 News & Press Releases

Applied BioCode Announces 2022 Q4 and Full year Revenue

02/28/2023

Strong Growth in Multiplex IVD and Steady Contribution from Technology Platform Partnerships February 27, 2023 8:47 AM Eastern Standard Time …

2022 News & Press Releases

Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer

03/24/2022

Applied BioCode announced today that Chris Bernard has been appointed as their new Chief Executive Officer (CEO). Mr. Bernard joins …

2022 News & Press Releases

Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States

03/14/2022

Hardy Diagnostics Now Offers the BioCode® MDx-3000 Exclusive U.S. Distribution of the Automated High Throughput Multiplex Molecular Diagnostic System March …

2021 News & Press Releases

Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay

12/16/2021

Applied BioCode announced today that it has received Emergency Use Authorization (EUA) from the US FDA for its BioCode® CoV-2 …

News and Articles

Applied BioCode Announces Distribution Agreement with Medline Industries

How to Improve Accessibility to Testing for GI Infections

Applied BioCode Announces 2022 Q4 and Full year Revenue

Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer

Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States

Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay

Search

Categories